Advertisement

Topics

Capital Genomix Company Profile

12:29 EST 20th November 2017 | BioPortfolio

Capital Genomix possesses two proprietary technology platforms for the comprehensive analysis of genes and proteins. We are pursuing a strategy that will combine the two platforms to identify genes and protein targets for life science research applications ranging from basic research to drug discovery to molecular diagnostics. Below, we provide an introduction to our two technology platforms, GeneSystem320TM and ImmunoMouseâ„¢.

Location

2 Cessna Court
Gaithersburg
MD
20879
United States of America

Contact

Phone: 240-401-2801
Fax: 301-948-9442
Email: info@capitalgenomix.com


News Articles [395 Associated News Articles listed on BioPortfolio]

Soligenix Announces Closing of $5,115,000 Concurrent Registered Direct Offering and Private ...

Lead investors in the financing included Knoll Capital Management, LP and ACT Capital Management, LLLP. Aegis Capital Corp. acted as the sole placement agent for Read more...

Sinovac scooped up by consortium and becomes private

Vaccines developer Sinovac Biotech Ltd. is being acquired by a consortium consisting of the company's president and CEO Yin, SAIF, C-Bridge Capital, Advantech Capital, and Vivo Capital.

Ankon raises $100mm

Ankon Technologies Co. Ltd. (devices for gastric diagnosis) raised a $100mm in an undisclosed financing round from Softbank China Venture Capital, Dazhong Investment, Youshi Capital, and Tongsheng Cap...

Rand Capital Announces Third Quarter 2017 Results

BUFFALO, NY--(Marketwired - November 06, 2017) -Rand Capital Corporation( NASDAQ : RAND) ("Rand"), a venture capital company which invests in growth Read more...

Late-Stage Life Sciences Investment Firm, Aisling Capital, Closes $280M Fund

Aisling Capital today announced the closing of its newest fund, with $280M in committed capital.

23andMe raises $250m in financing, research points towards its future

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had raised $250 million in financing and released details from a long-running study into Pa...

JHU alumni-run A-Level Capital to support AI-powered drug discovery at Insilico Medicine

(InSilico Medicine, Inc.) Insilico Medicine, Inc, announced an investment from A-Level Capital. A-Level Capital is an early-stage venture capital fund founded by the JHU alumni and students to support...

Rand Capital and Microcision Announce Microcision's Relocation to Support Growth

BUFFALO, NY--(Marketwired - July 11, 2017) -Rand Capital Corporation( NASDAQ : RAND) ("Rand"), a venture capital company which invests in growth Read more...

PubMed Articles [110 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

The effect of migration on social capital and depression among older adults in China.

An estimated 9 million elderly people accompanied their adult children to urban areas in China, raising concerns about their social capital and mental health following re-location. The aim of this stu...

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Evaluation of Four Reconstructions After Total Gastrectomy

There are four capital reconstructions after total gastrectomy which is widely used in China. Life quality is the only standard to evaluate postoperative results of different reconstructio...

Companies [1019 Associated Companies listed on BioPortfolio]

Capital Genomix, Inc.

Capital Genomix, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland that provides a unique, comprehensive solution for the discovery and rapid development of novel antibody-based ...

Capital Genomix

Capital Genomix possesses two proprietary technology platforms for the comprehensive analysis of genes and proteins. We are pursuing a strategy that will combine the two platforms to identify genes an...

Computable Genomix

Computable Genomix develops genetic biomarkers for pharmacogenomic and other applications. Using a cutting-edge computational approach, the company streamlines biomarker product d...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focus...

MCG Capital Corporation

MCG Capital Corporation is a solutions-focused commercial finance company providing capital and advisory services to middle-market companies throughout the United States. Our inve...

More Information about "Capital Genomix" on BioPortfolio

We have published hundreds of Capital Genomix news stories on BioPortfolio along with dozens of Capital Genomix Clinical Trials and PubMed Articles about Capital Genomix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Capital Genomix Companies in our database. You can also find out about relevant Capital Genomix Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record